GSTO1-IN-3
GSTO1-IN-3 is a potent GSTO1-1 inhibitor with an IC50 of 0.11 μM, and shows selectivity over GSTO2-2, GSTA1-1 and GSTP1-1 (IC50 > 100 μM). GSTO1-IN-3 enhances the cytotoxicity of Cisplatin against human breast cancer cells. GSTO1-IN-3 inhibits IL-1β release in mouse bone marrow-derived macrophage (BMDM) cells. GSTO1-IN-3 attenuates inflammation in mice. GSTO1-IN-3 can be used for breast cancer and inflammation research[1].
Product Specifications
CAS Number
158890-32-5
UNSPSC
12352005
Hazard Statement
H302-H315-H318-H335
Target
Glutathione S-transferase; Interleukin Related
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C(N1CCC(CC1)CC2=CC=CC=C2)CCl
Molecular Formula
C14H18ClNO
Molecular Weight
251.75
Precautions
P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P363-P405-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Texas Red Conjugated Goat Polyclonal Antibody to Human IgG
CD106 / VCAM1 (VCAM1/843), CF405S conjugate, 0.1mg/mL
